Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
Year: 2023
Type: article
Source: The Lancet Oncology
Authors: Heinz Ludwig, Evangelos Terpos, Niels van de Donk, Maria-Victoria Mateos, Philippe Moreau, Melitios-Athanasios Dimopoulos, Michel Delforge, Paula Rodriguez-Otero, Jesús San-Miguel, Kwee Yong, Francesca Gay, Hermann Einsele, Roberto Mina, Jo Caers, Christoph Driessen, Pellegrino Musto, Sonja Zweegman, Monika Engelhardt, Gordon Cook, Katja Weisel, Annemiek Broijl, Meral Beksac, Jelena Bila, Fredrik Schjesvold, Michele Cavo, Roman Hajek, Cyrille Touzeau, Mario Boccadoro, Pieter Sonneveld
Institutions: Wilhelminen Hospital, National and Kapodistrian University of Athens, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación del Cáncer, Centre Hospitalier Universitaire de Nantes, Nantes Université, KU Leuven, Navarre Institute of Health Research, Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, University College London, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, University of Turin, Universitätsklinikum Würzburg, Centre Hospitalier Universitaire de Liège, Kantonsspital St. Gallen, Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari, University of Bari Aldo Moro, University Medical Center Freiburg, University of Leeds, Cancer Research UK Clinical Trials Unit, University Medical Center Hamburg-Eppendorf, Erasmus MC Cancer Institute, Ankara University, University of Belgrade, Univerzitetski Klinički Centar Srbije, Oslo University Hospital, University of Oslo, Istituto di Ematologia di Bologna, University of Bologna, University of Ostrava, University Hospital Ostrava
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: multiple myeloma, bispecific antibodies, chimeric antigen receptor T cells, cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome, cytopenia, hypogammaglobulinemia, infection, adverse event prevention, tocilizumab, anakinra, corticosteroids, premedication, step-up dosing, immunoglobulin prophylaxis
Open Access status: bronze
OpenAlex ID: W4378800539
